InsiderClue
Insiders · Profile

Prasad Raju

Chief Financial Officer at CRISPR Therapeutics. Filing since 15 Mar 2024. CIK 0001968317

Company
Date
Role
Action
Shares
Amount
Of holding
CRSP CRISPR Therapeutics AG
23 Mar 2026
Chief Financial Officer
Sold at will
3,708
$173.46K
19.2%
CRSP CRISPR Therapeutics AG
16 Mar 2026
Chief Financial Officer
Sold at will
9,869
$476.28K
41.7%
CRSP CRISPR Therapeutics AG
22 Jan 2026
Chief Financial Officer
Sold on a plan
34,972
$2.10M
83.8%
CRSP CRISPR Therapeutics AG
6 Jan 2026
Chief Financial Officer
Sold on a plan
29,700
$1.79M
81.4%
CRSP CRISPR Therapeutics AG
22 Dec 2025
Chief Financial Officer
Sold on a plan
10,000
$559.55K
59.6%
CRSP CRISPR Therapeutics AG
21 Mar 2025
Chief Financial Officer
Sold at will
2,197
$90.58K
11.6%
CRSP CRISPR Therapeutics AG
17 Mar 2025
Chief Financial Officer
Sold at will
3,762
$157.25K
22.8%
CRSP CRISPR Therapeutics AG
15 Mar 2024
Chief Financial Officer
Sold at will
3,524
$256.16K
35.2%
8 decisions on file.